secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001437749-25-010469
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision FY2024 revenue $420K, net loss $16.6M; Q4 rev $149K up 55% QoQ
--------------------------------------------------------------------------------

- Full year 2024 revenue $420 thousand; Q4 2024 revenue $149 thousand, sequential increase of 55% over Q3.
- Net loss for 2024 was $16.6 million, of which $7.5 million were non-cash charges; Q4 net loss $5.6 million.
- LockeT vascular closure device first sales began Q2 2024 and grew sequentially; 26 institutions evaluated by year-end.
- CE Mark for LockeT anticipated Q2 2025 with EU sales expected to start Q3 2025.
- New Chief Commercial Officer appointed Q2 2024; majority of sales team replaced and trained by Q3 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925010469/0001437749-25-010469-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925010469/vtak20250103_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-010469

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer